Insider · CIK 0001870900
Anil Chitkara
Files at EVLV (Evolv Technologies Holdings, Inc.). First filing Mar 4, 2025, latest Mar 3, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EVLV: Evolv Technologies Holdings, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | Evolv Technologies Holdings, Inc. | $330k 63,670 shares | -5% | +88% from low-39% from high | |
| 18Weak | Evolv Technologies Holdings, Inc. | $3.0M 360,000 shares | -24% | +283% from low-6% from high | |
| 21Weak | Evolv Technologies Holdings, Inc. | $238k 72,148 shares | -5% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 1, 2026 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Class A Common Stock | +53,430 | $0.00 | $0 | 1,328,530 | Mar 3, 2026 |
| Mar 1, 2026 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Class A Common Stock | +45,913 | $0.00 | $0 | 1,374,443 | Mar 3, 2026 |
| Mar 1, 2026 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Class A Common Stock | +37,878 | $0.00 | $0 | 1,412,321 | Mar 3, 2026 |
| Mar 2, 2026 | EVLV Evolv Technologies Holdings, Inc. | SOpen-market sale Class A Common Stock | -63,670 | $5.19 | $330k | 1,348,651 | Mar 3, 2026 |
| Mar 1, 2026 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -53,430 | $0.00 | $0 | 0 | Mar 3, 2026 |
| Mar 1, 2026 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -45,913 | $0.00 | $0 | 45,915 | Mar 3, 2026 |
| Mar 1, 2026 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -37,878 | $0.00 | $0 | 75,758 | Mar 3, 2026 |
| Mar 2, 2026 | EVLV Evolv Technologies Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +46,728 | $0.00 | $0 | 46,728 | Mar 3, 2026 |
| Oct 24, 2025 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Class A Common Stock10b5-1 | +70,581 | $0.24 | $17k | 1,345,681 | Oct 28, 2025 |
| Oct 24, 2025 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Class A Common Stock10b5-1 | +120,000 | $0.24 | $29k | 1,465,681 | Oct 28, 2025 |
| Oct 24, 2025 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Class A Common Stock10b5-1 | +49,419 | $0.42 | $21k | 1,515,100 | Oct 28, 2025 |
| Oct 24, 2025 | EVLV Evolv Technologies Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -70,581 | $8.20 | $579k | 1,444,519 | Oct 28, 2025 |
| Oct 24, 2025 | EVLV Evolv Technologies Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -120,000 | $8.20 | $984k | 1,324,519 | Oct 28, 2025 |
| Oct 24, 2025 | EVLV Evolv Technologies Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -49,419 | $8.20 | $405k | 1,275,100 | Oct 28, 2025 |
| Oct 27, 2025 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Class A Common Stock10b5-1 | +85,173 | $0.24 | $20k | 1,360,273 | Oct 28, 2025 |
| Oct 27, 2025 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Class A Common Stock10b5-1 | +34,827 | $0.42 | $15k | 1,395,100 | Oct 28, 2025 |
| Oct 27, 2025 | EVLV Evolv Technologies Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -120,000 | $8.20 | $984k | 1,275,100 | Oct 28, 2025 |
| Oct 24, 2025 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -70,581 | $0.00 | $0 | 988,497 | Oct 28, 2025 |
| Oct 24, 2025 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -120,000 | $0.00 | $0 | 868,497 | Oct 28, 2025 |
| Oct 24, 2025 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -49,419 | $0.00 | $0 | 611,795 | Oct 28, 2025 |
| Oct 27, 2025 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -85,173 | $0.00 | $0 | 783,324 | Oct 28, 2025 |
| Oct 27, 2025 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -34,827 | $0.00 | $0 | 576,968 | Oct 28, 2025 |
| Mar 1, 2025 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Class A Common Stock | +47,765 | $0.00 | $0 | 1,247,922 | Mar 4, 2025 |
| Mar 1, 2025 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Class A Common Stock | +53,413 | $0.00 | $0 | 1,301,335 | Mar 4, 2025 |
| Mar 1, 2025 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Class A Common Stock | +45,913 | $0.00 | $0 | 1,347,248 | Mar 4, 2025 |
| Mar 3, 2025 | EVLV Evolv Technologies Holdings, Inc. | SOpen-market sale Class A Common Stock | -72,148 | $3.30 | $238k | 1,275,100 | Mar 4, 2025 |
| Mar 1, 2025 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -47,765 | $0.00 | $0 | 0 | Mar 4, 2025 |
| Mar 1, 2025 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -53,413 | $0.00 | $0 | 53,430 | Mar 4, 2025 |
| Mar 1, 2025 | EVLV Evolv Technologies Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -45,913 | $0.00 | $0 | 91,828 | Mar 4, 2025 |
| Mar 3, 2025 | EVLV Evolv Technologies Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +113,636 | $0.00 | $0 | 113,636 | Mar 4, 2025 |
| Mar 3, 2025 | EVLV Evolv Technologies Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +85,227 | $0.00 | $0 | 85,227 | Mar 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.